Explain me follicles stimulating hormone

Reading File

Finding Sources

Searching the Web

follicle stimulating hormone FSH physiology mechanism of action

Reading File

Finding Sources

Reading File

Loading Image

I now have all the information needed for a thorough, well-sourced answer. Here it is:

Follicle-Stimulating Hormone (FSH)

1. What Is FSH?

FSH is a gonadotropin - a glycoprotein polypeptide hormone synthesized and secreted by gonadotropic cells of the anterior pituitary gland. It works closely with luteinizing hormone (LH) to regulate reproduction, gametogenesis, and sex steroid synthesis in both males and females.

2. Structure

FSH is a heterodimer consisting of two non-covalently linked subunits:

Alpha (α) subunit - 96 amino acids, identical to the α-subunit of LH, TSH, and hCG. This shared subunit explains why very high levels of one glycoprotein hormone can sometimes weakly activate receptors of another (e.g., very high hCG in pregnancy can stimulate TSH receptors, causing transient hyperthyroidism).
Beta (β) subunit - 111 amino acids, hormone-specific. The β-subunit confers FSH's unique biological activity and determines its receptor binding. The gene encoding FSHβ is on chromosome 11p13.

Goldman-Cecil Medicine, p. 1832

3. Regulation - The HPG Axis

FSH secretion is governed by the hypothalamic-pituitary-gonadal (HPG) axis:

Signal	Effect on FSH
GnRH (pulsatile) from hypothalamus	Stimulates FSH release
GnRH (continuous)	Suppresses FSH (used pharmacologically)
Inhibin B (from granulosa/Sertoli cells)	Inhibits FSH (negative feedback)
Activin	Enhances FSH synthesis
Estrogen (low-moderate levels)	Inhibits FSH (negative feedback)
Estrogen (high sustained levels)	Positive feedback - triggers LH/FSH surge

The hypothalamus releases GnRH in a pulsatile manner into the hypophyseal portal circulation. GnRH acts on G-protein-coupled receptors on gonadotropes to stimulate FSH and LH secretion. During puberty, this pulsatile pattern is initiated, triggering the pubertal increase in FSH and LH.

4. Mechanism of Action

FSH acts through G-protein-coupled receptors (GPCR) on target cell membranes. The receptor has:

An extracellular domain that binds FSH
A transmembrane domain
An intracellular domain that transduces the signal (via cAMP/PKA pathway)

Mutations in the extracellular domain can cause constitutive receptor activation (FSH-like state even without FSH present - e.g., precocious puberty). Conversely, loss-of-function mutations render the receptor insensitive, causing primary hypogonadism despite high FSH levels.

Goldman-Cecil Medicine, p. 1832

5. Physiological Actions

In Females

FSH receptors are located on granulosa cells of ovarian follicles.

Two-Cell, Two-Gonadotropin Theory (the central concept of ovarian steroidogenesis):

Two-Cell, Two-Gonadotropin Theory diagram showing LH acting on theca cells to produce androgens, and FSH acting on granulosa cells to aromatize those androgens into estrogens

LH stimulates theca cells to convert cholesterol → androstenedione and testosterone
These androgens diffuse into the adjacent granulosa cells
FSH stimulates granulosa cell aromatase, converting those androgens → estrone and estradiol
The two cell types must cooperate: granulosa cells lack the early steroidogenic enzymes; theca cells lack aromatase

Berek & Novak's Gynecology, p. 289

FSH during the menstrual cycle:

Early follicular phase - FSH stimulates growth of a cohort of primordial follicles from primary to antral stage
Positive feedback loop - estrogen in the follicle induces more FSH receptors on granulosa cells, making them more sensitive to FSH
FSH + estrogen promote LH receptor expression on granulosa cells, priming them for the LH surge
Dominant follicle selection - rising estrogen and inhibin B decrease FSH. Only the follicle with the most FSH receptors (richest estrogenic microenvironment) survives; all others undergo atresia
Pre-ovulatory surge - FSH rises 2-3x alongside the major LH surge (~16 hours before ovulation)

Guyton & Hall Medical Physiology, pp. 1017-1018; Berek & Novak's Gynecology, p. 290

In Males

FSH receptors are located on Sertoli cells (and seminiferous tubules).

FSH stimulates Sertoli cells to support sperm maturation and spermatogenesis
Sertoli cells produce inhibin B, which feeds back to suppress FSH
LH acts on Leydig cells to produce testosterone, which also supports spermatogenesis
Together, FSH + LH are required for complete, normal spermatogenesis

Goldman-Cecil Medicine, p. 1834

6. Normal Reference Ranges

FSH levels vary significantly by sex and life stage:

Condition	Approximate FSH Level
Adult males	1.5 - 12.4 IU/L
Follicular phase (females)	3.5 - 12.5 IU/L
Ovulatory surge	Up to ~20 IU/L
Luteal phase	1.7 - 7.7 IU/L
Postmenopause	25 - 135 IU/L (markedly elevated)
Prepubertal children	<2 IU/L

7. Clinical Significance

High FSH

Menopause / premature ovarian insufficiency (POI) - loss of ovarian follicles removes negative feedback
Primary hypogonadism in males (e.g., Klinefelter syndrome) - testicular failure removes inhibin feedback
FSH-secreting pituitary adenoma - rare; usually presents as a non-functional mass causing hypogonadism due to ineffective gonadotropin stimulation; men may develop testicular enlargement

Low FSH

Hypogonadotropic hypogonadism - failure at the hypothalamus or pituitary (e.g., Kallmann syndrome, pituitary tumor, anorexia nervosa)
Amenorrhea with low FSH and LH points to a central (hypothalamic or pituitary) cause, not an ovarian cause

FSH in Polycystic Ovary Syndrome (PCOS)

Chronic androgen excess suppresses hypothalamic-pituitary FSH secretion
Impaired FSH signaling prevents dominant follicle development → chronic anovulation

8. Pharmacological Uses

FSH preparations are used clinically for ovulation induction and assisted reproduction:

Preparation	Source	Route
Urofollitropin	Purified from postmenopausal urine	SC (previously IM)
Follitropin alfa (recombinant)	Recombinant DNA (mammalian cells)	SC
Follitropin beta (recombinant)	Recombinant DNA (differs in glycosylation)	SC
Menotropins (hMG)	Urine-derived; contains both FSH and LH	IM or SC

Indications:

Controlled ovarian hyperstimulation for IVF
Infertility due to hypogonadotropic hypogonadism (females and males)

Key toxicity: Ovarian hyperstimulation syndrome (OHSS) - excessive follicular development causing fluid shifts, ovarian enlargement, and risk of thrombosis. Multiple pregnancies are also a risk.

Katzung Basic & Clinical Pharmacology, p. 80-82; Goodman & Gilman, p. 954

Summary

FSH is the master regulator of follicular development in females and spermatogenesis in males. It operates within the HPG axis, stimulated by pulsatile GnRH and inhibited by inhibin and estrogen. Its two core actions - aromatase induction in granulosa cells (females) and Sertoli cell support (males) - make it indispensable for fertility. Clinically, FSH levels help distinguish between central (low FSH) and gonadal (high FSH) causes of reproductive failure, and recombinant FSH preparations are a cornerstone of modern assisted reproduction.

This is a shared conversation. Sign in to Orris to start your own chat.